John Sourbeer

Stock Analyst at UBS

(0.99)
# 3,870
Out of 5,044 analysts
40
Total ratings
45%
Success rate
-14.57%
Average return

Stocks Rated by John Sourbeer

West Pharmaceutical Services
Oct 24, 2025
Maintains: Buy
Price Target: $320$355
Current: $287.22
Upside: +23.60%
Qiagen
Aug 7, 2025
Maintains: Neutral
Price Target: $48$50
Current: $48.40
Upside: +3.31%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $170$240
Current: $182.03
Upside: +31.85%
Cryoport
Apr 1, 2025
Maintains: Buy
Price Target: $10$11
Current: $10.40
Upside: +5.77%
Stevanato Group
Mar 7, 2025
Maintains: Neutral
Price Target: $24$24
Current: $25.98
Upside: -9.55%
QuidelOrtho
Feb 13, 2025
Maintains: Neutral
Price Target: $43$45
Current: $29.48
Upside: +52.65%
Pacific Biosciences of California
Nov 11, 2024
Downgrades: Neutral
Price Target: $2
Current: $2.09
Upside: -4.31%
Illumina
Nov 5, 2024
Maintains: Neutral
Price Target: $133$145
Current: $100.35
Upside: +44.49%
Medpace Holdings
Mar 8, 2024
Maintains: Buy
Price Target: $452$480
Current: $596.48
Upside: -19.53%
Bruker
Mar 1, 2024
Maintains: Buy
Price Target: $94$102
Current: $38.64
Upside: +163.98%
Initiates: Neutral
Price Target: $50
Current: $13.59
Upside: +267.92%
Maintains: Buy
Price Target: $142$128
Current: $127.18
Upside: +0.64%